title: Successful treatment of primary cardiac lymphoma with atrioventricular nodal block.
abstract: A 69-year-old female suffering from third-degree atrioventricular block with syncope underwent permanent pacemaker implantation. However, she developed shortness of breath 2 months after the implantation. Blood tests revealed elevated levels of LDH, CRP, BNP, and SIL-2R. Transthoracic echocardiography showed thickened left and right atrial walls with mild pericardial effusion. A diagnosis was made based on a CT scan and histology. Although most primary cardiac malignant lymphomas are associated with a poor prognosis, the patient was treated successfully with chemotherapy.
authors.affiliation: Department of Cardiology, Kurashiki Central Hospital, Miwa, Okayama, Japan.
authors.forename: Sou
authors.initials: S
authors.lastname: Takenaka
authors.forename: Kazuaki
authors.initials: K
authors.lastname: Mitsudo
authors.forename: Katsumi
authors.initials: K
authors.lastname: Inoue
authors.forename: Tsuyoshi
authors.initials: T
authors.lastname: Goto
authors.forename: Kazushige
authors.initials: K
authors.lastname: Kadota
authors.forename: Satoki
authors.initials: S
authors.lastname: Fujii
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Yamamoto
authors.forename: Yasushi
authors.initials: Y
authors.lastname: Fuku
authors.forename: Akitoshi
authors.initials: A
authors.lastname: Hirono
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Tanaka
authors.forename: Masanao
authors.initials: M
authors.lastname: Taba
authors.forename: Atsushi
authors.initials: A
authors.lastname: Ikeda
authors.forename: Yoji
authors.initials: Y
authors.lastname: Kojima
authors.forename: Junpei
authors.initials: J
authors.lastname: Maekawa
authors.forename: Sachiko
authors.initials: S
authors.lastname: Maekawa
authors.forename: Natsuki
authors.initials: N
authors.lastname: Takahashi
authors.forename: Hajime
authors.initials: H
authors.lastname: Saeki
authors.forename: Yukinobu
authors.initials: Y
authors.lastname: Nakamura
authors.forename: Tatsuhito
authors.initials: T
authors.lastname: Oonishi
authors.forename: Natsuki
authors.initials: N
authors.lastname: Ueda
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D004334:Drug Administration Schedule; D005260:Female; D006327:Heart Block / Q000150:complications* / Q000628:therapy; D006338:Heart Neoplasms / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D016393:Lymphoma, B-Cell / Q000188:drug therapy* / Q000209:etiology; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy* / Q000209:etiology; D010138:Pacemaker, Artificial; D011239:Prednisolone / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011239:Prednisolone